PI3K/Akt signalling pathway and cancer
Top Cited Papers
- 1 April 2004
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 30 (2), 193-204
- https://doi.org/10.1016/j.ctrv.2003.07.007
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cellsOncogene, 2003
- Regulation of TRAIL Expression by the Phosphatidylinositol 3-Kinase/Akt/GSK-3 Pathway in Human Colon Cancer CellsJournal of Biological Chemistry, 2002
- ZD1839: targeting the epidermal growth factor receptor in cancer therapyExpert Opinion on Investigational Drugs, 2002
- Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cellsOncogene, 2001
- Molecular mechanisms underlying ErbB2/HER2 action in breast cancerOncogene, 2000
- NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancerThe EMBO Journal, 2000
- The Hallmarks of CancerCell, 2000
- Regulation of Protein Kinase BJournal of Receptors and Signal Transduction, 1999
- Amplification and overexpression of theAKT2 oncogene in a subset of human pancreatic ductal adenocarcinomasMolecular Carcinogenesis, 1998
- Antisense Oligonucleotides Demonstrate a Dominant Role of c-Ki-RAS Proteins in Regulating the Proliferation of Diploid Human FibroblastsPublished by Elsevier ,1996